Parametric Portfolio Associates’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALBO
PA
CC
ACH
DCMIC
PM
Parametric Portfolio Associates's ALBO Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Albireo Pharma Inc (ALBO) stake by 39% in Q1 2022, buying an estimated $526K and bringing the position to 63,616 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2443.
Parametric Portfolio Associates first reported a position in ALBO in Q1 2018 and has held it in 17 quarters since. The position peaked at $2.12M in Q2 2021. 110 funds tracked by Wall St. Rank hold ALBO as of Q1 2022.
- Parametric Portfolio Associates held 63,616 shares of Albireo Pharma Inc worth $1.9M as of Q1 2022.
- Parametric Portfolio Associates bought 17,969 Albireo Pharma Inc shares in Q1 2022, an estimated $526K.
- Albireo Pharma Inc made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2443 holding.
- Parametric Portfolio Associates first reported a position in Albireo Pharma Inc in Q1 2018 and has held it in 17 quarters since.
- Parametric Portfolio Associates's Albireo Pharma Inc position peaked at $2.12M in Q2 2021.
- 110 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.